Blinatumomab是一種雙特異性T細(xì)胞增殖劑(BiTE)。它使患者的T細(xì)胞能夠識(shí)別惡性B細(xì)胞。Blinatumomab分子結(jié)合兩個(gè)結(jié)合位點(diǎn):一個(gè)T細(xì)胞的CD3位點(diǎn)和一個(gè)靶B細(xì)胞的CD19位點(diǎn)。 Blinatumomab生物仿制藥-研究級(jí)該產(chǎn)品同種型對(duì)照: 緩沖液:ICH3002 濃度:5mg/ml 純度:>90% by SDS-PAGE 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.